COVID-19 Sample Collection Kits Market

Market Overview:

The global COVID-19 sample collection kits market size reached US$ 7.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 3.2% during 2024-2032.

COVID-19 sample collection kits refer to in-vitro diagnostic medical equipment utilized for collecting biological specimens for detecting the SARS-CoV-2 virus. It is a vital step in the effective diagnosis of an active infection of the novel coronavirus in the body. Various health organizations, such as the Centers for Disease Control and Prevention (CDC) and the United States Food and Drug Administration (USFDA), have introduced standard procedures and guidelines for manufacturers to develop COVID-19 sample collection and transport kits that are compatible with the recommended configurations. With the rising number of hospitals expanding their testing capabilities, the demand for COVID-19 collection sample kits is escalating across the globe.

The global COVID-19 sample collection kits market is primarily driven by the growing geriatric population and the increasing number of people suffering from chronic diseases who are more prone to COVID-19 infections. Besides this, governments of several countries are undertaking various initiatives to provide sample collection kits to the masses at an affordable price. The extensive research and development (R&D) activities by the manufacturers in collaboration with the regional authorities and suppliers are also propelling the market growth. For instance, the introduction of a 3D printed nasal swab prototype for commercial use by researchers at the University of South Florida Health has positively impacted the market growth. Furthermore, the availability of swabs in various configurations for the advanced detection of infections has also led to increased adoption of COVID-19 sample collection kits across multiple healthcare centers and hospitals.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global COVID-19 sample collection kits market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and site of collection.

Breakup by Product:

• Swabs
  • Nasopharyngeal (NP) swabs
  • Oropharyngeal (OP) swabs
  • Nasal swabs
• Viral Transport Media
• Blood Collection Kits
• Others
   

Breakup by Application:

• Diagnostics
• Research
   

Breakup by Site of Collection:

• Hospitals and Clinics
• Home Test
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, COPAN Diagnostics, Formlabs, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., Medline Industries Inc., Puritan Medical Products, Thermo Fisher Scientific Inc. and VIRCELL S.L.

Report Coverage:

Key Questions Answered in This Report:

• How has the global COVID-19 sample collection kits market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the site of collection?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global COVID-19 sample collection kits market and who are the key players?
• What is the degree of competition in the industry?